Atara Biotherapeutics Inc. (NASDAQ: ATRA)
$11.30
+0.8250 ( +7.88% ) 44.1K
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Market Data
Open
$11.30
Previous close
$10.47
Volume
44.1K
Market cap
$54.73M
Day range
$9.85 - $11.59
52 week range
$4.97 - $63.38
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 20, 2024 |
8-k | 8K-related | 14 | Jun 17, 2024 |
8-k | 8K-related | 13 | Jun 11, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
10-q | Quarterly Reports | 69 | May 09, 2024 |
8-k | 8K-related | 12 | May 09, 2024 |